No Data
No Data
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal
Institutions Profited After Candel Therapeutics, Inc.'s (NASDAQ:CADL) Market Cap Rose US$108m Last Week but Retail Investors Profited the Most
Gamestop, Adobe, Meta, Candel Therapeutics, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Trending Stocks Today | Candel Therapeutics Soars 84.16%
10 Health Care Stocks Whale Activity In Today's Session
Express News | Candel Therapeutics Shares Resume Trading